Floatz logo

132 assets in Cognitive Disorder

Therapeutic assets addressing Cognitive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Metformin
Cognitive Disorder
Fudan UniversityP4BB (70)
Ginkgo Biloba
Cognitive Disorder
Dr. Willmar Schwabe GmbH & Co. KGP4BB (69)
Ginkgo Biloba Extract
Cognitive Disorder
Hanyang UniversityP4BB (69)
Memantine
Cognitive Disorder
UNC Lineberger Comprehensive Cancer CenterP3BB (69)
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE
Cognitive Disorder
Akiva MintzP2/3BB (66)
Dalzanemdor
Cognitive Disorder
Supernus Pharmaceuticals, Inc.P2BB (66)
Methylphenidate
Cognitive Disorder
St. Jude Children's Research HospitalP4BB (66)
Atorvastatin
Cognitive Disorder
Monash UniversityP4BB (65)
Choline Alfoscerate
Cognitive Disorder
Chong Kun Dang PharmaceuticalP4BB (65)
Citalopram
Cognitive Disorder
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoP4BB (65)
Escitalopram
Cognitive Disorder
National Institute of Allergy and Infectious Diseases (NIAID)P4BB (65)
Gadobutrol
Cognitive Disorder
GuerbetP4BB (65)
Gadodiamide
Cognitive Disorder
GuerbetP4BB (65)
Jnj-54135419
Cognitive Disorder
Peking University First HospitalP4BB (65)
Emestedastat
Cognitive Disorder
Actinogen MedicalP2BB (64)
Vortioxetine
Cognitive Disorder
Brain and Cognition Discovery FoundationP2BB (64)
Gadoteridol
Cognitive Disorder
GuerbetP4B (63)
3-N-BUTYLPHTHALIDE
Cognitive Disorder
First Affiliated Hospital of Wenzhou Medical UniversityP4B (62)
Spironolactone
Cognitive Disorder
Emory UniversityP4B (62)
Mebufotenin
Cognitive Disorder
Johns Hopkins UniversityP2B (61)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Cognitive Disorder
Icahn School of Medicine at Mount SinaiP2B (60)
acd856
Cognitive Disorder
AlzeCure PharmaP1B (60)
agb101
Cognitive Disorder
AgeneBioP2/3B (60)
Amlodipine
Cognitive Disorder
Hospital Moinhos de VentoP3B (60)
Daoib
Cognitive Disorder
Chang Gung Memorial HospitalP2B (60)
Flutemetamol
Cognitive Disorder
Akiva MintzP3B (60)
Inidascamine
Cognitive Disorder
Recognify Life SciencesP2B (60)
Modafinil
Cognitive Disorder
University of MinnesotaP3B (60)
Rosuvastatin
Cognitive Disorder
Hospital Moinhos de VentoP3B (60)
Sertraline
Cognitive Disorder
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoP4B (60)
3-IODOBENZYLGUANIDINE (123I)
Cognitive Disorder
Mayo ClinicP4B (59)
Ioflupane
Cognitive Disorder
Mayo ClinicP4B (59)
mk-6240
Cognitive Disorder
NYU Langone HealthP3B (59)
Trazodone
Cognitive Disorder
Chinese University of Hong KongP4B (59)
Flortaucipir
Cognitive Disorder
University of PennsylvaniaP2B (58)
Gadobenate Dimeglumine
Cognitive Disorder
GuerbetP4B (58)
Daridorexant
Cognitive Disorder
University of RochesterP2B (57)
Donanemab
Cognitive Disorder
Eli Lilly and CompanyP2B (57)
Gnrh
Cognitive Disorder
Nelly PitteloudP2/3B (57)
Gonadorelin
Cognitive Disorder
Nelly PitteloudP2/3B (57)
Istradefylline
Cognitive Disorder
Virginia Commonwealth UniversityP2B (57)
Lenalidomide
Cognitive Disorder
St. Joseph's Hospital and Medical Center, PhoenixP2B (57)
Prednisone
Cognitive Disorder
Beijing Friendship HospitalP2B (57)
Risperidone
Cognitive Disorder
Hasanuddin UniversityP2B (57)
Trospium
Cognitive Disorder
European Group for Research In SchizophreniaP3B (57)
Xanomeline
Cognitive Disorder
European Group for Research In SchizophreniaP3B (57)
Physiologic Sodium Chloride Solution
Cognitive Disorder
Nelly PitteloudP2/3B (56)
Serine D-Form
Cognitive Disorder
University of MinnesotaP3B (56)
Flavone, 3,3',4',5,7-Pentahydroxy-
Cognitive Disorder
Zaparackas and Knepper LTDP2CCC (55)
Mitoquinol Mesilate
Cognitive Disorder
Mclean HospitalP2/3CCC (55)
Showing 1 to 50 of 132 assets
PreviousPage 1 of 3Next